β-2-Microglobulin
(β2m) forms amyloid fibrils in the
joints of patients undergoing hemodialysis treatment as a result of
kidney failure. In the presence of stoichiometric amounts of Cu(II),
β2m self-associates into discrete oligomeric species, including
dimers, tetramers, and hexamers, before ultimately forming amyloid
fibrils that contain no copper. To improve our understanding of whether
Cu(II) is unique in its ability to induce β2m amyloid formation
and to delineate the coordinative interactions that allow Cu(II) to
exert its effect, we have examined the binding of Ni(II) and Zn(II)
to β2m and the resulting influence that these metals have on
β2m aggregation. We find that, in contrast to Cu(II), Ni(II)
does not induce the oligomerization or aggregation of β2m, while
Zn(II) promotes oligomerization but not amyloid fibril formation.
Using X-ray absorption spectroscopy and new mass spectrometry-related
techniques, we find that different binding modes are responsible for
the different effects of Ni(II) and Zn(II). By comparing the binding
modes of Cu(II) with Ni(II), we find that Cu(II) binding to Asp59
and the backbone amide between the first two residues of β2m
are important for allowing the formation of amyloid-competent oligomers,
as Ni(II) appears not to bind these sites on the protein. The oligomers
formed in the presence of Zn(II) are permitted by this metal’s
ability to bridge two β2m units via His51. These oligomers,
however, are not able to progress to form amyloid fibrils because
Zn(II) does not induce the required structural changes near the N-terminus
and His31.